<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-06-16" modified="2018-01-31" version="163">
<accession>Q9NWT6</accession>
<accession>D3DR69</accession>
<accession>Q5W147</accession>
<accession>Q969Q7</accession>
<accession>Q9NPV5</accession>
<name>HIF1N_HUMAN</name>
<protein>
<recommendedName>
<fullName>Hypoxia-inducible factor 1-alpha inhibitor</fullName>
<ecNumber>1.14.11.30</ecNumber>
<ecNumber>1.14.11.n4</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Factor inhibiting HIF-1</fullName>
<shortName>FIH-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Hypoxia-inducible factor asparagine hydroxylase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">HIF1AN</name>
<name type="synonym">FIH1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Genes Dev." volume="15" first="2675" last="2686">
<title>FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.</title>
<authorList>
<person name="Mahon P.C."/>
<person name="Hirota K."/>
<person name="Semenza G.L."/>
</authorList>
<dbReference type="PubMed" id="11641274"/>
<dbReference type="DOI" id="10.1101/gad.924501"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INTERACTION WITH HIF1A; VHL AND HISTONE DEACETYLASES</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Signet-ring cell carcinoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT ALA-41</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 89-349</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Genes Dev." volume="16" first="1466" last="1471">
<title>FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.</title>
<authorList>
<person name="Lando D."/>
<person name="Peet D.J."/>
<person name="Gorman J.J."/>
<person name="Whelan D.A."/>
<person name="Whitelaw M.L."/>
<person name="Bruick R.K."/>
</authorList>
<dbReference type="PubMed" id="12080085"/>
<dbReference type="DOI" id="10.1101/gad.991402"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF HIS-199 AND ASP-201</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="26351" last="26355">
<title>Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.</title>
<authorList>
<person name="Hewitson K.S."/>
<person name="McNeill L.A."/>
<person name="Riordan M.V."/>
<person name="Tian Y.-M."/>
<person name="Bullock A.N."/>
<person name="Welford R.W."/>
<person name="Elkins J.M."/>
<person name="Oldham N.J."/>
<person name="Bhattacharya S."/>
<person name="Gleadle J.M."/>
<person name="Ratcliffe P.J."/>
<person name="Pugh C.W."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="12042299"/>
<dbReference type="DOI" id="10.1074/jbc.C200273200"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Biochem. J." volume="383" first="429" last="437">
<title>Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity.</title>
<authorList>
<person name="Lancaster D.E."/>
<person name="McNeill L.A."/>
<person name="McDonough M.A."/>
<person name="Aplin R.T."/>
<person name="Hewitson K.S."/>
<person name="Pugh C.W."/>
<person name="Ratcliffe P.J."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="15239670"/>
<dbReference type="DOI" id="10.1042/BJ20040735"/>
</citation>
<scope>DIMERIZATION</scope>
<scope>MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF LEU-340 AND ILE-344</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="9899" last="9904">
<title>Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.</title>
<authorList>
<person name="Koivunen P."/>
<person name="Hirsila M."/>
<person name="Gunzler V."/>
<person name="Kivirikko K.I."/>
<person name="Myllyharju J."/>
</authorList>
<dbReference type="PubMed" id="14701857"/>
<dbReference type="DOI" id="10.1074/jbc.M312254200"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="14391" last="14397">
<title>Substrate requirements of the oxygen-sensing asparaginyl hydroxylase factor-inhibiting hypoxia-inducible factor.</title>
<authorList>
<person name="Linke S."/>
<person name="Stojkoski C."/>
<person name="Kewley R.J."/>
<person name="Booker G.W."/>
<person name="Whitelaw M.L."/>
<person name="Peet D.J."/>
</authorList>
<dbReference type="PubMed" id="14734545"/>
<dbReference type="DOI" id="10.1074/jbc.M313614200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="14767" last="14772">
<title>Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).</title>
<authorList>
<person name="Cockman M.E."/>
<person name="Lancaster D.E."/>
<person name="Stolze I.P."/>
<person name="Hewitson K.S."/>
<person name="McDonough M.A."/>
<person name="Coleman M.L."/>
<person name="Coles C.H."/>
<person name="Yu X."/>
<person name="Hay R.T."/>
<person name="Ley S.C."/>
<person name="Pugh C.W."/>
<person name="Oldham N.J."/>
<person name="Masson N."/>
<person name="Schofield C.J."/>
<person name="Ratcliffe P.J."/>
</authorList>
<dbReference type="PubMed" id="17003112"/>
<dbReference type="DOI" id="10.1073/pnas.0606877103"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NFKB1 AND NFKBIA</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="3368" last="3373">
<title>Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways.</title>
<authorList>
<person name="Zheng X."/>
<person name="Linke S."/>
<person name="Dias J.M."/>
<person name="Zheng X."/>
<person name="Gradin K."/>
<person name="Wallis T.P."/>
<person name="Hamilton B.R."/>
<person name="Gustafsson M."/>
<person name="Ruas J.L."/>
<person name="Wilkins S."/>
<person name="Bilton R.L."/>
<person name="Brismar K."/>
<person name="Whitelaw M.L."/>
<person name="Pereira T."/>
<person name="Gorman J.J."/>
<person name="Ericson J."/>
<person name="Peet D.J."/>
<person name="Lendahl U."/>
<person name="Poellinger L."/>
</authorList>
<dbReference type="PubMed" id="18299578"/>
<dbReference type="DOI" id="10.1073/pnas.0711591105"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Biochem. J." volume="420" first="327" last="333">
<title>MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH).</title>
<authorList>
<person name="Webb J.D."/>
<person name="Muranyi A."/>
<person name="Pugh C.W."/>
<person name="Ratcliffe P.J."/>
<person name="Coleman M.L."/>
</authorList>
<dbReference type="PubMed" id="19245366"/>
<dbReference type="DOI" id="10.1042/BJ20081905"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PPP1R12A</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="30350" last="30359">
<title>Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1.</title>
<authorList>
<person name="Sakamoto T."/>
<person name="Seiki M."/>
</authorList>
<dbReference type="PubMed" id="19726677"/>
<dbReference type="DOI" id="10.1074/jbc.M109.019216"/>
</citation>
<scope>INTERACTION WITH APBA3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="Mol. Cell. Biol." volume="32" first="3095" last="3106">
<title>Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.</title>
<authorList>
<person name="Martinez-Noel G."/>
<person name="Galligan J.T."/>
<person name="Sowa M.E."/>
<person name="Arndt V."/>
<person name="Overton T.M."/>
<person name="Harper J.W."/>
<person name="Howley P.M."/>
</authorList>
<dbReference type="PubMed" id="22645313"/>
<dbReference type="DOI" id="10.1128/MCB.00201-12"/>
</citation>
<scope>INTERACTION WITH UBE3A</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="22784" last="22784">
<title>NECAB3 promotes activation of hypoxia-inducible factor-1 during normoxia and enhances tumourigenicity of cancer cells.</title>
<authorList>
<person name="Nakaoka H.J."/>
<person name="Hara T."/>
<person name="Yoshino S."/>
<person name="Kanamori A."/>
<person name="Matsui Y."/>
<person name="Shimamura T."/>
<person name="Sato H."/>
<person name="Murakami Y."/>
<person name="Seiki M."/>
<person name="Sakamoto T."/>
</authorList>
<dbReference type="PubMed" id="26948053"/>
<dbReference type="DOI" id="10.1038/srep22784"/>
</citation>
<scope>INTERACTION WITH NECAB3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="15351" last="15356">
<title>Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway.</title>
<authorList>
<person name="Dann C.E. III"/>
<person name="Bruick R.K."/>
<person name="Deisenhofer J."/>
</authorList>
<dbReference type="PubMed" id="12432100"/>
<dbReference type="DOI" id="10.1073/pnas.202614999"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH IRON AND 2-OXOGLUTARATE</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="1802" last="1806">
<title>Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.</title>
<authorList>
<person name="Elkins J.M."/>
<person name="Hewitson K.S."/>
<person name="McNeill L.A."/>
<person name="Seibel J.F."/>
<person name="Schlemminger I."/>
<person name="Pugh C.W."/>
<person name="Ratcliffe P.J."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="12446723"/>
<dbReference type="DOI" id="10.1074/jbc.C200644200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) IN COMPLEX WITH 786-826 OF HIF1A; IRON; ZINC AND 2-OXOGLUTARATE</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="7558" last="7563">
<title>Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau.</title>
<authorList>
<person name="Lee C."/>
<person name="Kim S.J."/>
<person name="Jeong D.G."/>
<person name="Lee S.M."/>
<person name="Ryu S.E."/>
</authorList>
<dbReference type="PubMed" id="12482756"/>
<dbReference type="DOI" id="10.1074/jbc.M210385200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS)</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="J. Am. Chem. Soc." volume="127" first="7680" last="7681">
<title>Selective inhibition of factor inhibiting hypoxia-inducible factor.</title>
<authorList>
<person name="McDonough M.A."/>
<person name="McNeill L.A."/>
<person name="Tilliet M."/>
<person name="Papamicael C.A."/>
<person name="Chen Q.Y."/>
<person name="Banerji B."/>
<person name="Hewitson K.S."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="15913349"/>
<dbReference type="DOI" id="10.1021/ja050841b"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) IN COMPLEX WITH IRON AND INHIBITOR</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="3293" last="3301">
<title>Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.</title>
<authorList>
<person name="Hewitson K.S."/>
<person name="Lienard B.M."/>
<person name="McDonough M.A."/>
<person name="Clifton I.J."/>
<person name="Butler D."/>
<person name="Soares A.S."/>
<person name="Oldham N.J."/>
<person name="McNeill L.A."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="17135241"/>
<dbReference type="DOI" id="10.1074/jbc.M608337200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH IRON; SUCCINATE AND FUMARATE</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="24027" last="24038">
<title>Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor.</title>
<authorList>
<person name="Coleman M.L."/>
<person name="McDonough M.A."/>
<person name="Hewitson K.S."/>
<person name="Coles C."/>
<person name="Mecinovic J."/>
<person name="Edelmann M."/>
<person name="Cook K.M."/>
<person name="Cockman M.E."/>
<person name="Lancaster D.E."/>
<person name="Kessler B.M."/>
<person name="Oldham N.J."/>
<person name="Ratcliffe P.J."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="17573339"/>
<dbReference type="DOI" id="10.1074/jbc.M704102200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) IN COMPLEXES WITH 1930-1949 OR 1997-2016 OF MOUSE NOTCH1; IRON AND 2-OXOGLUTARATE</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="25971" last="25978">
<title>Evidence that two enzyme-derived histidine ligands are sufficient for iron binding and catalysis by factor inhibiting HIF (FIH).</title>
<authorList>
<person name="Hewitson K.S."/>
<person name="Holmes S.L."/>
<person name="Ehrismann D."/>
<person name="Hardy A.P."/>
<person name="Chowdhury R."/>
<person name="Schofield C.J."/>
<person name="McDonough M.A."/>
</authorList>
<dbReference type="PubMed" id="18611856"/>
<dbReference type="DOI" id="10.1074/jbc.M804999200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 11-349 OF MUTANTS ALA-201 AND GLY-201 IN COMPLEXES WITH 786-826 OR 788-806 OF HIF1A; IRON OR ZINC AND 2-OXOGLUTARATE</scope>
<scope>MUTAGENESIS OF ASP-201; TRP-296 AND LEU-340</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem. Lett." volume="20" first="6125" last="6128">
<title>Structural basis for binding of cyclic 2-oxoglutarate analogues to factor-inhibiting hypoxia-inducible factor.</title>
<authorList>
<person name="Conejo-Garcia A."/>
<person name="McDonough M.A."/>
<person name="Loenarz C."/>
<person name="McNeill L.A."/>
<person name="Hewitson K.S."/>
<person name="Ge W."/>
<person name="Lienard B.M."/>
<person name="Schofield C.J."/>
<person name="Clifton I.J."/>
</authorList>
<dbReference type="PubMed" id="20822901"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2010.08.032"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.12 ANGSTROMS) IN COMPLEX WITH IRON AND 2-OXOGLUTARATE ANALOGS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Mol. Cells" volume="29" first="471" last="474">
<title>Crystal structures of human FIH-1 in complex with quinol family inhibitors.</title>
<authorList>
<person name="Moon H."/>
<person name="Han S."/>
<person name="Park H."/>
<person name="Choe J."/>
</authorList>
<dbReference type="PubMed" id="20396966"/>
<dbReference type="DOI" id="10.1007/s10059-010-0058-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 15-349 IN COMPLEX WITH IRON AND QUINOL FAMILY INHIBITORS</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="EMBO Rep." volume="12" first="463" last="469">
<title>The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.</title>
<authorList>
<person name="Chowdhury R."/>
<person name="Yeoh K.K."/>
<person name="Tian Y.M."/>
<person name="Hillringhaus L."/>
<person name="Bagg E.A."/>
<person name="Rose N.R."/>
<person name="Leung I.K."/>
<person name="Li X.S."/>
<person name="Woon E.C."/>
<person name="Yang M."/>
<person name="McDonough M.A."/>
<person name="King O.N."/>
<person name="Clifton I.J."/>
<person name="Klose R.J."/>
<person name="Claridge T.D."/>
<person name="Ratcliffe P.J."/>
<person name="Schofield C.J."/>
<person name="Kawamura A."/>
</authorList>
<dbReference type="PubMed" id="21460794"/>
<dbReference type="DOI" id="10.1038/embor.2011.43"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) IN COMPLEX WITH IRON AND INHIBITORS</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="FEBS J." volume="278" first="1086" last="1097">
<title>Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.</title>
<authorList>
<person name="Yang M."/>
<person name="Chowdhury R."/>
<person name="Ge W."/>
<person name="Hamed R.B."/>
<person name="McDonough M.A."/>
<person name="Claridge T.D."/>
<person name="Kessler B.M."/>
<person name="Cockman M.E."/>
<person name="Ratcliffe P.J."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="21251231"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2011.08022.x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) IN COMPLEX WITH IRON; 2-OXOGLUTARATE AND 538-558 OF TNKS2</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="7648" last="7660">
<title>Asparagine and aspartate hydroxylation of the cytoskeletal ankyrin family is catalyzed by factor-inhibiting hypoxia-inducible factor.</title>
<authorList>
<person name="Yang M."/>
<person name="Ge W."/>
<person name="Chowdhury R."/>
<person name="Claridge T.D."/>
<person name="Kramer H.B."/>
<person name="Schmierer B."/>
<person name="McDonough M.A."/>
<person name="Gong L."/>
<person name="Kessler B.M."/>
<person name="Ratcliffe P.J."/>
<person name="Coleman M.L."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="21177872"/>
<dbReference type="DOI" id="10.1074/jbc.M110.193540"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF MUTANT HIS-239 IN COMPLEX WITH ZINC; N-OXALYLGLYCINE AND PEPTIDE SUBSTRATE</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ANK1</scope>
<scope>MUTAGENESIS OF ASP-201 AND GLN-239</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<comment type="function">
<text evidence="15 16 23 25 26 28 32 33">Hydroxylates HIF-1 alpha at 'Asn-803' in the C-terminal transactivation domain (CAD). Functions as an oxygen sensor and, under normoxic conditions, the hydroxylation prevents interaction of HIF-1 with transcriptional coactivators including Cbp/p300-interacting transactivator. Involved in transcriptional repression through interaction with HIF1A, VHL and histone deacetylases. Hydroxylates specific Asn residues within ankyrin repeat domains (ARD) of NFKB1, NFKBIA, NOTCH1, ASB4, PPP1R12A and several other ARD-containing proteins. Also hydroxylates Asp and His residues within ARDs of ANK1 and TNKS2, respectively. Negatively regulates NOTCH1 activity, accelerating myogenic differentiation. Positively regulates ASB4 activity, promoting vascular differentiation.</text>
</comment>
<comment type="catalytic activity">
<text evidence="15 16 20 25">Hypoxia-inducible factor-L-asparagine + 2-oxoglutarate + O(2) = hypoxia-inducible factor-(3S)-3-hydroxy-L-asparagine + succinate + CO(2).</text>
</comment>
<comment type="catalytic activity">
<text evidence="33">[Ankyrin-repeat domain protein]-L-histidine + 2-oxoglutarate + O(2) = [ankyrin-repeat domain protein]-(3S)-3-hydroxy-L-histidine + succinate + CO(2).</text>
</comment>
<comment type="catalytic activity">
<text evidence="23 25 26 28 32">[Ankyrin-repeat domain protein]-L-asparagine + 2-oxoglutarate + O(2) = [ankyrin-repeat domain protein]-(3S)-3-hydroxy-L-asparagine + succinate + CO(2).</text>
</comment>
<comment type="catalytic activity">
<text evidence="32">[Ankyrin-repeat domain protein]-L-aspartate + 2-oxoglutarate + O(2) = [ankyrin-repeat domain protein]-(3S)-3-hydroxy-L-aspartate + succinate + CO(2).</text>
</comment>
<comment type="cofactor">
<cofactor evidence="17 18 22 24 30 31 33 34">
<name>Fe(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29033"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="20">100 uM for HIF1A (788-822) peptide</KM>
<KM evidence="20">160 uM for HIF2A (832-866) peptide</KM>
<KM evidence="20">0.5 uM for Fe(2+)</KM>
<KM evidence="20">25 uM for 2-oxoglutarate</KM>
<KM evidence="20">260 uM for ascorbate</KM>
<KM evidence="20">90 uM for O(2)</KM>
<text>The kinetic constants are determined for the recombinant FLAG-His-tagged protein.</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="12 14 17 18 19 20 22 23 24 25 28 29 30 31 32 33 34 35 36">Homodimer; homodimerization is essential for catalytic activity. Interacts with VHL and HIF1A. Part of a complex with VHL, HIF1A and HDAC1 or HDAC2 or HDAC3. Interacts with NFKB1 and NFKBIA. Interacts with NOTCH1, NOTCH2 and NOTCH3 but not with NOTCH4. Interacts with APBA3; binding inhibits HIF1AN binding to HIF1A. Interacts with TNKS2. Interacts with PPP1R12A. Interacts with ASB4 (By similarity). Interacts with UBE3A. Interacts with ANKS3 (By similarity). Interacts with NECAB3; the interaction is indirect and seems to be mediated by APBA3.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-6115839">
<id>O96018</id>
<label>APBA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-745641">
<id>Q96DX5</id>
<label>ASB9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-310482">
<id>Q9UK73</id>
<label>FEM1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-747644">
<id>Q13418</id>
<label>ILK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-307386">
<id>P25963</id>
<label>NFKBIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-1058491">
<id>Q96FW1</id>
<label>OTUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-752185">
<id>O75832</id>
<label>PSMD10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-4422308">
<id>P57078</id>
<label>RIPK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-1105254">
<id>O95271</id>
<label>TNKS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-4398527">
<id>Q9H2K2</id>
<label>TNKS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745632"/>
<interactant intactId="EBI-350510">
<id>Q9BZF9</id>
<label>UACA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>perinuclear region</location>
</subcellularLocation>
<text>Mainly cytoplasmic localization, but interaction with NOTCH1 results in nuclear localization and interaction with ABPA3 results in perinuclear localization in macrophages.</text>
</comment>
<comment type="mass spectrometry" mass="40566" method="Electrospray" evidence="21">
<location>
<begin position="1"/>
<end position="349"/>
</location>
</comment>
<dbReference type="EC" id="1.14.11.30"/>
<dbReference type="EC" id="1.14.11.n4"/>
<dbReference type="EMBL" id="AF395830">
<property type="protein sequence ID" value="AAL27308.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK000622">
<property type="protein sequence ID" value="BAA91291.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133352">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49817.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49818.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007719">
<property type="protein sequence ID" value="AAH07719.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL359615">
<property type="protein sequence ID" value="CAB94885.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7498.1"/>
<dbReference type="PIR" id="T50633">
<property type="entry name" value="T50633"/>
</dbReference>
<dbReference type="RefSeq" id="NP_060372.2">
<property type="nucleotide sequence ID" value="NM_017902.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.500788"/>
<dbReference type="PDB" id="1H2K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="1H2L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="1H2M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="1H2N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.84"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="1IZ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="1MZE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="1MZF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="1YCI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2CGN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2CGO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2ILM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2W0X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2WA3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2WA4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2XUM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2Y0I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.28"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2YC0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="2YDE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.28"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="3D8C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=11-349"/>
</dbReference>
<dbReference type="PDB" id="3KCX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=15-349"/>
</dbReference>
<dbReference type="PDB" id="3KCY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="A=15-349"/>
</dbReference>
<dbReference type="PDB" id="3OD4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="3P3N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="3P3P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="4AI8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="4B7E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="4B7K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="4BIO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="4JAA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="4NR1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="4Z1V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="4Z2W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="5JWK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="5JWL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="5JWP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="5OP6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="5OP8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDB" id="5OPC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-349"/>
</dbReference>
<dbReference type="PDBsum" id="1H2K"/>
<dbReference type="PDBsum" id="1H2L"/>
<dbReference type="PDBsum" id="1H2M"/>
<dbReference type="PDBsum" id="1H2N"/>
<dbReference type="PDBsum" id="1IZ3"/>
<dbReference type="PDBsum" id="1MZE"/>
<dbReference type="PDBsum" id="1MZF"/>
<dbReference type="PDBsum" id="1YCI"/>
<dbReference type="PDBsum" id="2CGN"/>
<dbReference type="PDBsum" id="2CGO"/>
<dbReference type="PDBsum" id="2ILM"/>
<dbReference type="PDBsum" id="2W0X"/>
<dbReference type="PDBsum" id="2WA3"/>
<dbReference type="PDBsum" id="2WA4"/>
<dbReference type="PDBsum" id="2XUM"/>
<dbReference type="PDBsum" id="2Y0I"/>
<dbReference type="PDBsum" id="2YC0"/>
<dbReference type="PDBsum" id="2YDE"/>
<dbReference type="PDBsum" id="3D8C"/>
<dbReference type="PDBsum" id="3KCX"/>
<dbReference type="PDBsum" id="3KCY"/>
<dbReference type="PDBsum" id="3OD4"/>
<dbReference type="PDBsum" id="3P3N"/>
<dbReference type="PDBsum" id="3P3P"/>
<dbReference type="PDBsum" id="4AI8"/>
<dbReference type="PDBsum" id="4B7E"/>
<dbReference type="PDBsum" id="4B7K"/>
<dbReference type="PDBsum" id="4BIO"/>
<dbReference type="PDBsum" id="4JAA"/>
<dbReference type="PDBsum" id="4NR1"/>
<dbReference type="PDBsum" id="4Z1V"/>
<dbReference type="PDBsum" id="4Z2W"/>
<dbReference type="PDBsum" id="5JWK"/>
<dbReference type="PDBsum" id="5JWL"/>
<dbReference type="PDBsum" id="5JWP"/>
<dbReference type="PDBsum" id="5OP6"/>
<dbReference type="PDBsum" id="5OP8"/>
<dbReference type="PDBsum" id="5OPC"/>
<dbReference type="ProteinModelPortal" id="Q9NWT6"/>
<dbReference type="SMR" id="Q9NWT6"/>
<dbReference type="BioGrid" id="120794">
<property type="interactions" value="79"/>
</dbReference>
<dbReference type="DIP" id="DIP-35527N"/>
<dbReference type="IntAct" id="Q9NWT6">
<property type="interactions" value="144"/>
</dbReference>
<dbReference type="MINT" id="MINT-1465958"/>
<dbReference type="STRING" id="9606.ENSP00000299163"/>
<dbReference type="BindingDB" id="Q9NWT6"/>
<dbReference type="ChEMBL" id="CHEMBL5909"/>
<dbReference type="DrugBank" id="DB01694">
<property type="generic name" value="D-tartaric acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB08263">
<property type="generic name" value="N-(carboxycarbonyl)-D-phenylalanine"/>
</dbReference>
<dbReference type="DrugBank" id="DB09459">
<property type="generic name" value="Tartaric acid"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9NWT6"/>
<dbReference type="PhosphoSitePlus" id="Q9NWT6"/>
<dbReference type="BioMuta" id="HIF1AN"/>
<dbReference type="DMDM" id="32129605"/>
<dbReference type="EPD" id="Q9NWT6"/>
<dbReference type="MaxQB" id="Q9NWT6"/>
<dbReference type="PaxDb" id="Q9NWT6"/>
<dbReference type="PeptideAtlas" id="Q9NWT6"/>
<dbReference type="PRIDE" id="Q9NWT6"/>
<dbReference type="DNASU" id="55662"/>
<dbReference type="Ensembl" id="ENST00000299163">
<property type="protein sequence ID" value="ENSP00000299163"/>
<property type="gene ID" value="ENSG00000166135"/>
</dbReference>
<dbReference type="GeneID" id="55662"/>
<dbReference type="KEGG" id="hsa:55662"/>
<dbReference type="UCSC" id="uc001krj.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="55662"/>
<dbReference type="DisGeNET" id="55662"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000166135.13"/>
<dbReference type="GeneCards" id="HIF1AN"/>
<dbReference type="HGNC" id="HGNC:17113">
<property type="gene designation" value="HIF1AN"/>
</dbReference>
<dbReference type="HPA" id="CAB069903"/>
<dbReference type="HPA" id="HPA048742"/>
<dbReference type="HPA" id="HPA065302"/>
<dbReference type="MIM" id="606615">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NWT6"/>
<dbReference type="OpenTargets" id="ENSG00000166135"/>
<dbReference type="PharmGKB" id="PA29284"/>
<dbReference type="eggNOG" id="KOG2132">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQDR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000062914"/>
<dbReference type="HOGENOM" id="HOG000008146"/>
<dbReference type="HOVERGEN" id="HBG051903"/>
<dbReference type="InParanoid" id="Q9NWT6"/>
<dbReference type="KO" id="K18055"/>
<dbReference type="OMA" id="MIKGRYD"/>
<dbReference type="OrthoDB" id="EOG091G0C8E"/>
<dbReference type="PhylomeDB" id="Q9NWT6"/>
<dbReference type="TreeFam" id="TF329609"/>
<dbReference type="BioCyc" id="MetaCyc:HS15407-MONOMER"/>
<dbReference type="BRENDA" id="1.14.11.16">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1234162">
<property type="pathway name" value="Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9NWT6"/>
<dbReference type="ChiTaRS" id="HIF1AN">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9NWT6"/>
<dbReference type="GeneWiki" id="HIF1AN"/>
<dbReference type="GenomeRNAi" id="55662"/>
<dbReference type="PRO" id="PR:Q9NWT6"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000166135"/>
<dbReference type="CleanEx" id="HS_HIF1AN"/>
<dbReference type="ExpressionAtlas" id="Q9NWT6">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NWT6">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071532">
<property type="term" value="F:ankyrin repeat binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031406">
<property type="term" value="F:carboxylic acid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048037">
<property type="term" value="F:cofactor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0102113">
<property type="term" value="F:hypoxia-inducible factor-asparagine oxygenase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0005506">
<property type="term" value="F:iron ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051059">
<property type="term" value="F:NF-kappaB binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005112">
<property type="term" value="F:Notch binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016706">
<property type="term" value="F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019826">
<property type="term" value="F:oxygen sensor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036140">
<property type="term" value="F:peptidyl-asparagine 3-dioxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036139">
<property type="term" value="F:peptidyl-histidine dioxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045746">
<property type="term" value="P:negative regulation of Notch signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061428">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055114">
<property type="term" value="P:oxidation-reduction process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042265">
<property type="term" value="P:peptidyl-asparagine hydroxylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042264">
<property type="term" value="P:peptidyl-aspartic acid hydroxylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036138">
<property type="term" value="P:peptidyl-histidine hydroxylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045663">
<property type="term" value="P:positive regulation of myoblast differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001214">
<property type="term" value="P:positive regulation of vasculogenesis"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061418">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to hypoxia"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.287.1010">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR027445">
<property type="entry name" value="FIH-1"/>
</dbReference>
<dbReference type="InterPro" id="IPR027452">
<property type="entry name" value="FIH-1_dom_II"/>
</dbReference>
<dbReference type="InterPro" id="IPR003347">
<property type="entry name" value="JmjC_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12461:SF51">
<property type="entry name" value="PTHR12461:SF51"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00558">
<property type="entry name" value="JmjC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51184">
<property type="entry name" value="JMJC"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0223">Dioxygenase</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="initiator methionine" description="Removed" evidence="9 10 11">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Hypoxia-inducible factor 1-alpha inhibitor" id="PRO_0000083974">
<location>
<begin position="2"/>
<end position="349"/>
</location>
</feature>
<feature type="domain" description="JmjC" evidence="13">
<location>
<begin position="142"/>
<end position="312"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with VHL" evidence="14">
<location>
<begin position="2"/>
<end position="125"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="32">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="32">
<location>
<begin position="201"/>
<end position="203"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="32">
<location>
<begin position="238"/>
<end position="239"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; via tele nitrogen; catalytic" evidence="17 18 22 24 30 31 33 34">
<location>
<position position="199"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; catalytic" evidence="17 18 22 24 30 31 33 34">
<location>
<position position="201"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; via tele nitrogen; catalytic" evidence="17 18 22 24 30 31 33 34">
<location>
<position position="279"/>
</location>
</feature>
<feature type="binding site" description="2-oxoglutarate" evidence="17 18 33">
<location>
<position position="145"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="32">
<location>
<position position="152"/>
</location>
</feature>
<feature type="binding site" description="2-oxoglutarate" evidence="17 18 33">
<location>
<position position="196"/>
</location>
</feature>
<feature type="binding site" description="2-oxoglutarate" evidence="17 18 33">
<location>
<position position="205"/>
</location>
</feature>
<feature type="binding site" description="2-oxoglutarate" evidence="17 18 33">
<location>
<position position="214"/>
</location>
</feature>
<feature type="binding site" description="2-oxoglutarate" evidence="17 18 33">
<location>
<position position="294"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via amide nitrogen" evidence="32">
<location>
<position position="300"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="32">
<location>
<position position="321"/>
</location>
</feature>
<feature type="site" description="Important for dimer formation">
<location>
<position position="340"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="9 10 11">
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2295778." id="VAR_051028" evidence="37">
<original>P</original>
<variation>A</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents suppression of HIF CAD activity. Strongly stimulates 2-oxoglutarate turnover. No stimulation of 2-oxoglutarate turnover; when associated with R-340." evidence="16">
<original>H</original>
<variation>A</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents suppression of HIF CAD activity." evidence="16 27 32">
<original>D</original>
<variation>A</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of HIF1A Asn hydroxylation activity. Slightly stimulates 2-oxoglutarate turnover." evidence="16 27 32">
<original>D</original>
<variation>E</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="mutagenesis site" description="No impact on HIF1A Asn hydroxylation activity. Loss of Asp hydroxylation ability. Strongly stimulates 2-oxoglutarate turnover. Loss of HIF1A Asn hydroxylation activity and slight stimulation of 2-oxoglutarate turnover; when associated with R-296." evidence="16 27 32">
<original>D</original>
<variation>G</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on Asp hydroxylation ability." evidence="32">
<original>Q</original>
<variation>H</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of HIF1A Asn hydroxylation activity and slight stimulation of 2-oxoglutarate turnover; when associated with G-201." evidence="27">
<original>W</original>
<variation>R</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs dimer formation, leading to loss of HIF1A Asn hydroxylation activity. No stimulation of 2-oxoglutarate turnover; when associated with A-201." evidence="21 27">
<original>L</original>
<variation>R</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on dimer formation and HIF1A Asn hydroxylation activity." evidence="21">
<original>I</original>
<variation>R</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAA91291." ref="2" evidence="38">
<original>A</original>
<variation>T</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAA91291." ref="2" evidence="38">
<original>D</original>
<variation>H</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAA91291." ref="2" evidence="38">
<original>R</original>
<variation>G</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="2"/>
<end position="9"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="20"/>
<end position="22"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="24"/>
<end position="26"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="29"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="39"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="50"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="62"/>
<end position="65"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="71"/>
<end position="75"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="78"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="85"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="90"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="105"/>
<end position="107"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="117"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="125"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="143"/>
<end position="149"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="151"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="156"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="167"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="182"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="186"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="195"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="202"/>
<end position="212"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="214"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="224"/>
<end position="227"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="235"/>
<end position="238"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="239"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="244"/>
<end position="246"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="249"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="253"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="260"/>
<end position="265"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="270"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="278"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="290"/>
<end position="298"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="312"/>
<end position="329"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="330"/>
<end position="332"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="333"/>
<end position="335"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="336"/>
<end position="344"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="345"/>
<end position="347"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MZE"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2WA3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2YC0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3D8C"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KCY"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OD4"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3P3P"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Z1V"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8BLR9"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00538"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11641274"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12042299"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12080085"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12432100"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12446723"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12482756"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14701857"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15239670"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15913349"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17003112"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17135241"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17573339"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18299578"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18611856"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19245366"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19726677"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20396966"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20822901"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21177872"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21251231"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21460794"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22645313"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26948053"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="38" type="ECO:0000305"/>
<sequence length="349" mass="40285" checksum="96A033BA7B3BD8C7" modified="2003-06-16" version="2">
MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEE
PVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNR
EEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWG
QLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQS
QVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGA
PTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>